-
1
-
-
19444366641
-
European Nicotinamide Diabetes Intervention Trial
-
Gale EAM + ENDIT Group Members, European Nicotinamide Diabetes Intervention Trial. Lancet 2004;363:925-931
-
(2004)
Lancet
, vol.363
, pp. 925-931
-
-
Gale, E.A.M.1
-
2
-
-
0020644050
-
Characteristics of nicotinamide and N′-methylnicotinamide. Protection from alloxan diabetes in mice
-
L.J. Fischer, J. Falany, and R. Fisher Characteristics of nicotinamide and N′-methylnicotinamide. Protection from alloxan diabetes in mice Toxicol Appl Pharmacol 70 1983 148 155
-
(1983)
Toxicol Appl Pharmacol
, vol.70
, pp. 148-155
-
-
Fischer, L.J.1
Falany, J.2
Fisher, R.3
-
3
-
-
0020366489
-
Methylation of nicotinamide in rat liver cytosol and its correlation with hepatocellular proliferation
-
J. Hoshino, U. Kuehne, and H. Kroeger Methylation of nicotinamide in rat liver cytosol and its correlation with hepatocellular proliferation Biochim Biophys Acta 719 3 1982 518 526
-
(1982)
Biochim Biophys Acta
, vol.719
, Issue.3
, pp. 518-526
-
-
Hoshino, J.1
Kuehne, U.2
Kroeger, H.3
-
4
-
-
0020378624
-
Enhancement of DNA synthesis and cell proliferation by 1-methylnicotinamide in rat liver cells in culture
-
J. Hoshino, U. Kuehne, and H. Kroeger Enhancement of DNA synthesis and cell proliferation by 1-methylnicotinamide in rat liver cells In culture Biochem Biophys Res Commun 105 4 1982 1446 1452
-
(1982)
Biochem Biophys Res Commun
, vol.105
, Issue.4
, pp. 1446-1452
-
-
Hoshino, J.1
Kuehne, U.2
Kroeger, H.3
-
5
-
-
12444253946
-
1-Methylnicotinamide: A potent anti-inflammatory agent of vitamin origin
-
J. Gebicki, A. Sysa-Jedrzejowska, J. Adamus, A. Wozniacka, M. Rybak, and J. Zielonka 1-Methylnicotinamide: a potent anti-inflammatory agent of vitamin origin Pol J Pharmacol 55 2003 109 112
-
(2003)
Pol J Pharmacol
, vol.55
, pp. 109-112
-
-
Gebicki, J.1
Sysa-Jedrzejowska, A.2
Adamus, J.3
Wozniacka, A.4
Rybak, M.5
Zielonka, J.6
-
6
-
-
0006684160
-
Protection against diabetes with nicotinamide
-
A. Lazarow, J. Liambies, and A.J. Tausch Protection against diabetes with nicotinamide J Lab Clin Med 36 1950 249 258
-
(1950)
J Lab Clin Med
, vol.36
, pp. 249-258
-
-
Lazarow, A.1
Liambies, J.2
Tausch, A.J.3
-
7
-
-
15244352421
-
The role of the liver and kidney in the metabolism of nicotinamide in pellagrins and nonpellagrins
-
M.S. El Ridi, M.M. Abdel Kader, and A. Habib The role of the liver and kidney in the metabolism of nicotinamide in pellagrins and nonpellagrins Acta Physiol Acad Sci Hung 17 1960 429 441
-
(1960)
Acta Physiol Acad Sci Hung
, vol.17
, pp. 429-441
-
-
El Ridi, M.S.1
Abdel Kader, M.M.2
Habib, A.3
-
8
-
-
15244340131
-
Tryptophan-nicotinic acid pathway in diabetes mellitus
-
G. Pasquariello Tryptophan-nicotinic acid pathway in diabetes mellitus Acta Vitaminol 18 5 1964 225 234
-
(1964)
Acta Vitaminol
, vol.18
, Issue.5
, pp. 225-234
-
-
Pasquariello, G.1
-
9
-
-
15244362496
-
Nicotinamide coenzyme levels in the livers of alloxan-diabetic rats
-
T. Matsuura, I. Miyata, and H. Kurata Nicotinamide coenzyme levels in the livers of alloxan-diabetic rats Bitamin 37 1968 423 427
-
(1968)
Bitamin
, vol.37
, pp. 423-427
-
-
Matsuura, T.1
Miyata, I.2
Kurata, H.3
-
10
-
-
0038188660
-
Reduced tubular cation transport in diabetes: Prevented by ACE inhibition
-
M.C. Thomas, C.B. Tikellis, and W.C. Burns Reduced tubular cation transport in diabetes: prevented by ACE inhibition Kidney Internat 63 6 2003 2152 2161
-
(2003)
Kidney Internat
, vol.63
, Issue.6
, pp. 2152-2161
-
-
Thomas, M.C.1
Tikellis, C.B.2
Burns, W.C.3
|